psychische stoornissen: aandachtstekortstoornis met hyperactiviteit ADHD Attention Deficit Hyperactivity Disorder
Conditions
Interventions
None listed
Sponsors
Rijksuniversiteit Groningen
Eligibility
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the healthy control group: • Age of 12 to 16 years, inclusive 16. • Intelligence score of IQ >= 80 • Both adolescent and parents/caretakers are willing to sign informed consent;General inclusion criteria for patients diagnosed with ADHD: • Age of 12 to 16 years, inclusive 16. • Diagnosed with ADHD according to DSM-IV-TR: all subtypes are allowed • Intelligence score of IQ >= 80 • Both adolescent and parents/caretakers are willing to sign informed consent;Extra inclusion criteria for the specific medication groups: Medication-free: • No psychopharmaca usage during the past year; no psychopharmaca prescribed by clinician.;On stimulants: • Regular intake of stimulant medication, as prescribed by the clinician (co-medication with other psychopharmaca is allowed). • Intake of the regular dose of stimulant medication on the day of the assessment;Off stimulants: • Regular intake of stimulant medication, as prescribed by the clinician (co-medication with other psychopharmaca is allowed). • Discontinuation of stimulant medication intake on the day of the assessment • Willing to delay stimulant medication intake for this study. If not, the participant is excluded.
Exclusion criteria
Exclusion criteria: Healthy controls: • Attendance of primary school. All participants should have made the transition from primary to secondary school because this is a major life event for adolescents that impacts on various aspects of their lives, including their social life, which is important for the development of social-cognitive functions. • Psychiatric diagnosis confirmed by clinician • Signs of clinical psychopathology as assessed with the Child Behavioural Checklist (see section 4.3 Study procedures) • Signs of clinical ADHD, as assessed with the Conners* Parent Rating Scale (see section 4.3 Study procedures) • Signs of clinical autistic spectrum disorder (ASD) as screened with the Social Communication Scale (see section 4.3 Study procedures).;ADHD groups: • The ADHD-diagnosis is not confirmed by the semi-structured Parent Interview Schedule for Child symptoms (PICS-5: Schachar, Ickowicz, Sugarman, 2008) and the Teacher Telephone Interview (TTI) administered by the researchers. If recent scores (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performance on tasks for social cognition of the ADHD groups is compared to the healthy control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The performance on social cognition of patients with ADHD on stimulants is compared to the performance of ADHD patients without stimulant medication (medication-free and stimulants off). Furthermore, the following additional measures will be used to predict the performance on social cognition measures and daily social functioning: 1) task performance on tests for executive functions, and 2) scores on a range of questionnaires on social functioning in daily life. | — |
Countries
Netherlands
Outcome results
None listed